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A b S T R A C T
Objective: To assess the peroperative and oncological results of laparoscopic adrenalectomy 
for an isolated metastasis.
Material and methods: A retrospective, descriptive study was conducted of 12 laparoscopic 
adrenalectomies performed for metastases out of a total of 40 adrenalectomies performed 
from May 1998 to April 2009. The primary tumor was pulmonary in 7 patients, renal in 3, 
and colonic in 2. Demographic data collected included median age, operating time, blood 
loss, complications, tumor size, and length of hospital stay. The Kaplan-Meier method was 
used to analyze survival.
Results: Operating time was 150 min (range, 90-206). Peroperative bleeding was 60 ml 
(range, 15-150). Peroperative complications occurred in 3% of patients. Tumor size was 4.5 
cm (range, 1.3-8.5). No positive margins were seen in the resected specimens. Hospital stay 
was 3 days (range 3-5). Actuarial survival was 55.6% at 23 months (range, 2-38) with mean 
and median follow-up times of 20.9 and 23 months.
Conclusions: In selected patients, laparoscopic adrenalectomy for metastasis is a safe 
procedure with oncological results superimposable to those of open surgery.
 © 2009 AEU. Published by Elsevier España, S.L. All rights reserved.
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Adrenalectomía laparoscópica por metástasis metácrona. Experiencia  
en 12 casos
R E S U M E N
Objetivos: evaluar los resultados perioperatorios y oncológicos de la adrenalectomía lapa-
roscópica por metástasis aislada.
Material y métodos: estudio retrospectivo y descriptivo de 12 adrenalectomías laparoscópi-
cas por metástasis de un total de 40 realizadas entre mayo de 1998 y abril de 2009. El tumor 
primario fue en siete casos de pulmón, en tres renal y en dos de colon. Los datos demo-
gráficos de la serie incluyeron edad, tiempo operatorio, sangrado, complicaciones, tamaño 
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Introduction 
The adrenal glands have a rich supply of fine blood vessels 
that that may promote the implantation and development of 
metastases. The tumors that most often metastasize to the 
adrenal gland are carcinomas of the lung, breast, colon, kidney, 
and melanoma, though there have been reports of metastasis 
of other origin, such as stomach and ovary1. The detection of 
solitary adrenal metastases discovered during the follow-up 
of cancer patients provides a greater chance of survival when 
compared to patients with synchronous metastasis2. 
Since the description in 1992 of the laparoscopic approach 
to the adrenal gland, there has been constant controversy on 
the use of this type of procedure for the treatment of primary 
and metastatic malignant tumors of the adrenal gland, with 
series having been reported with long survival following 
laparoscopic adrenalectomy for cancer2,3. 
The purpose of this study was to perform a retrospective 
and descriptive analysis of the perioperative and oncological 
results of laparoscopic adrenalectomy for a solitary 
metachronous metastasis. 
Materials and methods 
A retrospective, descriptive study of 12 solitary adrenal 
metastases (mets) from a series of 40 laparoscopic 
adrenalectomies performed from May 1998 to April 2009. 
Solitary metastases were found in 10 patients, two of whom 
had bilateral mets, synchronous in one case and metachronous 
in the other. Met was on the left side in 7 patients and on the 
right in 5. The primary tumor was pulmonary in 7 patients, 
renal in 3, and colonic in 2. All patients were males, with a 
median age of 59.5 years (range: 49-70). Preoperative staging 
was performed in all cases by computed tomography (CT) 
and/or positron emission tomography (PET). Demographic 
data collected included median age, operating time, blood 
loss, complications, tumor size, and length of hospital stay. 
Mandatory informed consent was obtained In all patients. 
Mechanical bowel preparation was performed from 24 hours 
before surgery that included a liquid diet and laxatives. 
Thromboembolic prophylaxis was administered with low 
molecular weight heparin, cross-matched to reserve 2 units 
of compatible blood. On the same day, a broad-spectrum 
antibiotic (third-generation cephalosporin) was administered. 
Surgical details regarding patient placement, approach, 
number and position of trocars, and surgical technique had 
been previously described4. 
Statistical analysis 
Statistical data are expressed as the mean and median. 
Actuarial survival was performed using the Kaplan-Meier 
method. Student’s t test or the log-rank test was used 
for comparison of means, considering a p-value < 0.05 as 
statistically significant. 
Results 
A total of 12 solitary adrenal mets were operated using the 
laparoscopic approach in 10 patients, of which one had 
synchronous bilateral disease and the other metachronous. 
Median operating time was 150 minutes (range: 90-206). 
Median blood loss was 60 mL (range: 15-50). There was one 
intraoperative complication from splenic capsular tear (3%), 
treated conservatively. Mean tumor size was 4.5 cm (range: 
1.3-8.5). Pathological analysis revealed malignancy related to 
the primary tumor in all cases. No positive margins were seen 
in the resected specimens. Median hospital stay was three 
days (range: 3-5). Demographic, surgical and pathological 
characteristics of the series are detailed in Table 1. 
Adrenal metastases of pulmonary origin 
These were the largest group (n = 7; one patient with 
synchronous bilateral metastasis [Fig. 1]). The predominant 
cell pattern was classic large cell carcinoma, except in 
one patient (case 8), in whom a squamous pattern with 
severe cytoplasmic immune reactivity to cytokeratins 
predominated. In all cases, systemic chemotherapy regimens 
were instituted with various drugs and schemes, preferably 
cisplatin, carboplatin, taxotere, gemcitabine and paclitaxel, 
before or after treating the primary tumor. 
tumoral y estancia hospitalaria expresados como mediana. El análisis de supervivencia se 
hizo con el método de Kaplan-Meier.
Resultados: el tiempo operatorio fue de 150 minutos (rango 90 a 206). El sangrado intrao-
peratorio fue de 60 cc (rango 15 a 150). Hubo complicaciones intraoperatorias en el 3% de 
los casos. El tamaño tumoral fue de 4,5 cm (rango 1,3 a 8,5). No se observaron márgenes 
positivos en las piezas de resección. La estancia hospitalaria fue de tres días (rango 3 a 5). 
La supervivencia actuarial fue del 55,6% a los 23 meses (rango 2 a 38), con una media y 
mediana de seguimiento de 20,9 y 23 meses, respectivamente.
Conclusiones: la adrenalectomía laparoscópica por metástasis en pacientes seleccionados es 
una técnica segura con resultados oncológicos superponibles a los de la cirugía abierta.
© 2009 AEU. Publicado por Elsevier España, S.L. Todos los derechos reservados.
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Adrenal metastases of renal origin 
Of the three patients from the series, two had the shortest 
follow-up (three and two months, respectively), and one of 
them had an associated myelolipoma in pathological analysis 
of the resected specimen. Case 2, who had a met in the 
contralateral adrenal gland, had the longest follow-up, and is 
currently disease-free. 
Adrenal metastases of intestinal origin 
One patient (case 5 and 9) was diagnosed in June 2005 
with rectal adenocarcinoma at 5 cm from the anal canal. 
The patient was treated with a chemotherapy scheme of 
oxaliplatin, irinotecan and capecitabine, and 4 additional 
cycles of cytoreductive radiotherapy before abdominoperineal 
amputation and terminal colostomy performed in November 
2005. In July 2006 and February 2007, laparoscopic 
adrenalectomy was performed for metachronous mets, 
followed by three cycles of gemcitabine, oxaliplatin and 
ertibux. The patient is currently disease-free. 
Survival analysis 
All patients in the series (n = 10) were followed up until the 
end of the observation period or death. Mean and median 
Figure 1 – Synchronous bilateral adrenal metastasis of poorly differentiated lung carcinoma. A: Abdominal computed 
tomography (CT) showing the increase in both adrenal (asterisks). B: Positron emission tomography with 18FDG showing 
increased metabolism in both adrenal glands (arrows), consistent with metastasis.
Case no.  Age Sex Side Size (cm) Pathological diagnosis Outcome Follow-up 
(months)
1 59 Male Left 3 Lung cancer metastasis Dead. Progression 21
2 54 Male Right 4.5 Renal cancer metastasis Alive. No disease 38
3 70 Male Left 3.5 Lung cancer metastasis Dead. Progression 24
4 60 Male Left 5 Poorly differentiated lung Dead. Progression 21 
     cancer metastasis
5* 65 Male Right 6.8 Colon cancer metastasis Alive. No disease 34
6** 67 Male bilateral 8.5/5 Poorly differentiated lung Dead. Progression 6 
     cancer metastasis
7 49 Male Right 5 Lung cancer metastasis Alive. With disease 32
8 70 Male Left 4.5 Poorly differentiated squamous Alive. No disease 30 
     lung cancer metastasis
9* 65 Male Left 1.3 Colon cancer metastasis Alive. No disease 26
10 53 Male Right 3.7 Renal cancer metastasis. Myelolipoma Alive. No disease 3
11 57 Male Left 1.5 Renal cancer metastasis Alive. No disease 2
 
*Metachronous metastasis of rectal cancer in the same patient, with a difference of 7 months; **synchronous lung cancer metastasis in the 
same patient.
Table 1 – Demographic, surgical and pathological characteristics of the series
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follow-up times were 20.9 and 23 months. At the end of the 
study, 6 patients (60%) were alive, one of them with stabilized 
pulmonary disease. Actuarial survival for the overall group, 
estimated using the of Kaplan-Meier method, was 55.6% at 
two years. Survival, using the same statistical method, for 
patients diagnosed with pulmonary mets—the largest group 
in this series, with a mean and median follow-up of 21.8 and 
21 months—was 33.3% at two years. Using Student’s t test 
or the log-rank test for comparison of means, no statistically 
significant difference in survival was found in patients with 
mets of pulmonary origin compared with overall survival 
(p = 0.09). 
Discussion 
In this study we assessed perioperative and oncological results 
in a group of patients with metachronous adrenal metastases 
who were treated with laparoscopic adrenalectomy. The 
presence of adrenal met should be suspected in any patient 
with a previous history of cancer who has a adrenal tumor 
greater than 2 cm in diameter. When they are found, they are 
usually accompanied by multiple synchronous mets in other 
organs; the finding of a solitary adrenal met is less common5. 
The indication of laparoscopic surgery for a solitary adrenal 
met remains controversial, as is also the case for a suspected 
primary adrenal carcinoma. The criterion that should prevail 
in these cases, in addition to the experience of the surgeon in 
this type of procedure, is careful patient selection based on 
whether the tumor is confined to the gland in the imaging 
studies performed (CT, MRI) and whether the principles of 
oncologic surgery are followed2,3. 
There are few series of laparoscopic adrenalectomies for 
cancer or met published in the literature with more than 
10 cases1,3. In our study, all adrenalectomies were done 
for metachronous mets of the same tumor type previously 
diagnosed and treated. This circumstance of becoming 
evident an interval of time after initial presentation is less 
common than those found synchronously with the primary 
tumor5. Most adrenal mets have been traditionally detected 
in the large post-mortem series in patients with disseminated 
disease. Adrenal mets of pulmonary origin account for 
approximately 35.6% of the total, somewhat less than those 
of breast origin, which are the most common, and which are 
usually found during a radiological study in patients with 
known neoplastic disease, or more rarely as a sign of adrenal 
insufficiency due to unilateral or bilateral destruction of 
adrenal tissue6. 
The incidence of adrenal met of renal origin in a recent 
series of 1,179 patients treated for renal carcinoma was 
3.7%, 1.9% of which were ipsilateral, 1.5% contralateral, 
and 0.3% bilateral, synchronous with the primary tumor in 
2.7% of patients and metachronous in 1%7. Adrenal mets of 
colorectal and other organ origins were reported with a much 
lower incidence in the series consulted1,2. In the present 
series, the proportion of mets over total adrenalectomies 
was 30%, a much higher figure than the average reported 
in other series where they accounted for less than 2% of 
the operated cases. This disproportion could be explained 
by the fact that our center is a national reference center for 
oncological disease. 
Tumor size is another factor that has been widely 
discussed when indicating a laparoscopic or open approach 
to the adrenal gland. In our series, the largest tumor diameter 
was 8.5 cm, which posed no problems during surgery, 
since the imaging studies conducted had ruled out local 
infiltration or of adjacent organs. A study comparing the role 
of laparoscopic adrenalectomy to open surgery in tumors less 
than or greater than 6 cm concluded that results are similar 
in the absence of local invasion8. Similarly, when a correct 
preoperative assessment is performed, the possibility of 
intraoperative complications decreases. In our study we had 
a low complications rate of 3% due to a splenic capsular tear 
treated conservatively. In other series consulted, the average 
complication rate ranged from 9% to 12.5% of patients1. 
During the follow-up of our series, we did not observe the 
presence of tumor implants in the peritoneal cavity or the 
port sites used for laparoscopic surgery, although in one case 
rupture of the endobag occurred at the time of collection of 
the surgical specimen. 
The possibility of positive margins following laparoscopic 
adrenalectomy for suspected met is low, although special 
care should be taken during dissection, particularly when 
periadrenal fat tissue is very dense, ill-defined or adhered 
to nearby structures. Some authors advise against use of 
the harmonic scalpel for dissection of periadrenal tissue 
because of the possibility of causing tumor implants from 
viable neoplastic cells contained in the vapor generated by 
the scalpel. In our experience, using the harmonic scalpel 
routinely, we noted no presence of peritoneal or port site 
implants in this series. The percentage of positive margins 
ranges, depending on the authors, at around 9%3; this is 
a low figure, possibly resulting from previous selection in 
patients with suspected neoplastic disease. In our series, 
one patient had involvement of periadrenal fat tissue, 
although the final margins in pathological analysis were 
negative. 
Timing of adrenal met appears to influence patient survival. 
A systematic review with a total of 114 patients on the 
outcomes of adrenalectomy for isolated synchronous versus 
metachronous adrenal mets in lung cancer observed that 
mean survival was shorter in patients with synchronous met 
that those with metachronous met (12 versus 31 months; p = 
0.02), although estimated survival at 5 years was equivalent 
with 26% and 25%. respectively9. The authors did not find 
conclusive factors for the better prognosis of metachronous 
mets, but postulated a possible relationship between 
morbidity and mortality associated with thoracotomy in 
synchronous mets and more aggressive biological behavior 
as factors influencing survival. In the case of metachronous 
met of renal carcinoma. disease-free survival increases 
significantly, depending on the series, to 87% after 39 months 
of follow-up10. In our experience, though it is a small 
series, metachronous adrenal mets of pulmonary origin did 
not show a statistically significant difference in survival 
compared with overall survival (p = 0.09), but the limitation 
of the number of cases and follow-up of the patients should 
be taken into account. 
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Conclusions 
Laparoscopic adrenalectomy for met in adequately selected 
patients has been shown to be a safe and feasible technique. 
Our data show that the therapeutic and oncological results 
are superimposable to those of open surgery, with a survival 
for metachronous adrenal met at 3 years higher than 50%. 
Although the literature supports the surgical indication in 
patients with adrenal met, prospective studies are lacking 
to demonstrate that resection of a solitary adrenal met 
increases patient survival. Therefore, studies are needed 
including a greater number of patients and longer follow-up 
to confirm this possibility. 
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